000952 Hubei Guangji Pharmaceutical
- 4.90
- -0.08-1.61%
Hubei Guangji Pharmaceutical News
Guangji Pharmaceutical: Legal Opinion Witnessing the 2024 Second Extraordinary General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd.
Guangji Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Guangji Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Guangji Pharmaceutical: Semi-Annual Report 2024
Guangji Pharmaceutical: 2024 Semi-Annual Financial Report
Guangji Pharmaceutical: Announcement of Resolutions of the Supervisory Board in the Semi-Annual Report
Guangji Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Guangji Pharmaceutical: 2024 Semi-Annual Report Summary
Hubei Guangji Pharmaceutical: Notice Regarding the Holding of the Second Extraordinary Shareholders' Meeting in 2024.
Hubei Guangji Pharmaceutical: Announcement on Resignation of Independent Director and Election of Independent Director
Hubei Guangji Pharmaceutical: Announcement of the resolution of the 43rd (temporary) meeting of the 10th Board of Directors.
Hubei Guangji Pharmaceutical: Statement and Commitment of Independent Director Candidate (Guo Wei)
Hubei Guangji Pharmaceutical: Opinion of the 10th board of directors' nomination committee on the qualification review of independent director candidates.
Hubei Guangji Pharmaceutical: Statement and commitment of the independent director nominee (Guo Wei)
Hubei Guangji Pharmaceutical: Announcement regarding the completion of the cancellation of a portion of restricted share buyback under the 2021 Restricted Stock Incentive Plan.
Hubei Guangji Pharmaceutical: 2024 Interim Performance Forecast
Hubei Guangji Pharmaceutical: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Hubei Guangji Pharmaceutical: Legal Opinion on Witnessing the 2024 First Extraordinary General Meeting of Shareholders of Hubei Guangji Pharmaceutical Co., Ltd. by Beijing Jing Shi (Wuhan) Law Firm
Hubei Guangji Pharmaceutical: Notice to creditors regarding the reduction of registered capital by repurchasing and canceling restricted stocks.
Hubei Guangji Pharmaceutical: Announcement of Resolutions of the 40th (Interim) Meeting of the 10th Board of Supervisors
Analysis
Price Target
No Data
